Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stage I Pulmonary Adenocarcinoma
- Sponsor
- IRCCS San Raffaele
- Enrollment
- 58
- Locations
- 1
- Primary Endpoint
- Stratification of stage I adenocarcinoma patients, using clinical data derived from preoperative CT and PET
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The clinical and derived data from the preoperative computed axial tomography (CT) and Positron Emission Tomography (PET) of patients with pathological stage I pulmonary adenocarcinoma will be analyzed retrospectively, classified according to the current pathological classification IASLC / ATS / ERS of pulmonary adenocarcinoma, subjected to surgical treatment in our Operating Unit between August 2006 and July 2011. A follow-up will be performed on the patients enrolled in the study up to the date of death, and in any case no later than October 31, 2019
Investigators
Prof. Carretta Angelo
Principal Investigator
IRCCS San Raffaele
Eligibility Criteria
Inclusion Criteria
- •patients suffering from pulmonary adenocarcinoma in stage I underwent CT, PET and surgical treatment with radical intent, at San Raffale Hospital (thoracic surgery) between August 2006 and July 2011
Exclusion Criteria
- •primary pulmonary neoplasms other than adenocarcinoma; locally advanced or metastatic disease stage; non-radical resection.
Outcomes
Primary Outcomes
Stratification of stage I adenocarcinoma patients, using clinical data derived from preoperative CT and PET
Time Frame: 12 months
classify patients with pulmonary adenocarcinoma in stage I (retrospective cases) based on the current pathological classification IASLC / ATS / ERS of pulmonary adenocarcinoma using clinical data and derived from preoperative CT and PET